TITLE

Whole-body hyperthermia: a review of theory, design and application

AUTHOR(S)
Vertrees, Roger A; Leeth, Angela; Girouard, Mark; Roach, John D; Zwischenberger, Joseph B
PUB. DATE
July 2002
SOURCE
Perfusion;Jul2002, Vol. 17 Issue 4, p279
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The intentional induction of elevated body temperature to treat malignant lesions has its origins in the 18th century. The mechanism of heat-induced cell death is not clear; however, heat induces a variety of cellular changes. For heat to exert a therapeutic effect, pathogens (bacteria, viruses, or neoplastic tissues) need to be susceptible within temperature ranges that do not exert deleterious effects on normal tissues. Hyperthermia has been used successfully to treat isolated neoplastic lesions of the head and neck, regional tumors such as melanoma of the limb, and is under investigation as either an adjunct to, or therapy for, locally disseminated and systemic diseases. The clinical utility of perfusion hyperthermia has evolved into three approaches - isolated organ or limb, tumorous invasion of a cavity, and systemic or metastatic spread. When wholebody hyperthermic treatment has been tried, it has been induced in the patient by submersion in hot wax or liquid, wrapping in plastic, encasement in a high-flow water perfusion suit, or by extracorporeal perfusion. Our group has developed an extracorporeal method, veno-venous perfusion-induced systemic hyperthermia, that was used first to safely heat swine homogenously to an average body temperature of 43 °C for 2 h. More recently, a Phase I clinical trial has been completed in which all patients were safely heated to 42 or 42.5 °C for 2 h and survived the 30-day study period. We have been sufficiently encouraged by these results and are continuing to develop this technology.
ACCESSION #
7105439

 

Related Articles

  • Hyperthermia trials expand.  // AIDS Patient Care & STDs;Aug96, Vol. 10 Issue 4, p264 

    Reports on the upcoming expanded studies of extracorporeal whole-body hyperthermia therapy (WBHT) for treatment of HIV/AIDS. Sites for clinical trials; Safety of the Biologic-HT System and the efficacy of the WHBT; Artificial induction of fever as treatment.

  • Thermotheraphy can avoid radiation, hospitalization. Zabel, Karen // Ophthalmology Times;03/15/97, Vol. 22 Issue 6, p8 

    Presents a report from Jerry Shields at the 1997 Macula meeting on the advantages of thermotherapy in the treatment of intraocular tumors. Avoidance of surgery, plaque application, ionizing radiation, and hospitalization; Thermotherapy's cytotoxic effect on tumor cells; Other uses of...

  • A hotfoot for HIV? M.O.R. // Cortlandt Forum;10/25/97, Vol. 10 Issue 10, p136 

    Focuses on the absence of any indication for the use of hyperthemia in treating any infectious diseases such as central nervous system syphilis, severe rheumatoid arthritis or HIV infections. Theory on the curative power of high fever.

  • A primer on how hot, cold therapy work.  // Chain Drug Review;2/14/2011, Vol. 33 Issue 3, p35 

    The article offers information on the mechanisms of cold therapy and heat therapy in relieving pain.

  • PUTTING THE HEAT ON.  // Overdrive;Apr2004, Vol. 44 Issue 4, p96 

    Discusses the significance of heat therapy, an inexpensive and effective way to deal back and neck pain, the common ailments in truck drivers. Health benefits of heat treatment; Applications of heat therapy; Limitations of heat treatment.

  • Oncology Outpatient and Provider Responses to a Computerized Symptom Assessment System. Carpenter, Janet S.; Rawl, Susan; Porter, Jennifer; Schmidt, Karen; Tornatta, Jennifer; Ojewole, Foluso; Helft, Paul; Potter, David A.; Sweeney, Christopher; Giesler, R. Brian // Oncology Nursing Forum;Jul2008, Vol. 35 Issue 4, p661 

    Purpose/Objectives: To assess patient and provider responses to a computerized symptom assessment system.Design: Descriptive, longitudinal study with retrospective, longitudinal medical records review.Setting: University-based National Cancer Institute-designated outpatient cancer center.Sample:...

  • New nonsurgical BPH tx approved. Guttman, Cheryl // Urology Times;Jun96, Vol. 24 Issue 6, p42 

    Reports on the approval by the US Food and Drug Administration of the Prostatron, a microwave device for non-surgical treatment of symptomatic benign prostatic hyperplasia. Transurethral microwave thermotherapy as procedure; Development of the device by EDAP Technomed Inc.; Contact information.

  • Fever Therapy in Oncology. Parmar, Gurdev // Townsend Letter;Aug/Sep2013, Issue 361/362, p66 

    The article explores potential of fever therapy in oncology. It acknowledges unpleasant symptoms which may be attributed to fever, which is deemed an immunologic response of the body to infection. It describes inverse connection between febrile illnesses and subsequent cancer risk. Brief details...

  • Turn up the heat.  // Alive: Canada's Natural Health & Wellness Magazine;Mar2006, Issue 281, p18 

    The article provides information about hyperthermic therapy. It is a significant aid in cleansing and healing the body since heat is capable of cleaning clogged pores, drawing out toxins and killing harmful bacteria and viruses. It has also the capacity of increasing the metabolism, circulation...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics